Literature DB >> 26506983

Shifting to 4 × 1 intermittent catheterization without an early follow-up urodynamic study is possible in most patients with subacute spinal cord injury.

Murat Ersöz1,2, Engin Koyuncu2, Müfit Akyüz2, Neşe Özgirgin2.   

Abstract

OBJECTIVES: We retrospectively evaluated the frequency of changing to 4/day intermittent catheterization (IC) in patients with subacute spinal cord injury (SCI) who had been initiated on IC 6 times a day and started oral anticholinergic treatment following urodynamic investigation for decreased maximum cystometric capacity and undergone a follow-up urodynamic study within 45 days. The goal of the study was to see if the second urodynamic study was necessary.
METHODS: The frequency of shifting to 4/day IC was investigated retrospectively in 27 patients with subacute SCI who were prescribed 6/day IC.
RESULTS: In 25 of 27 patients a bladder capacity of 400 ml or more was reached in urodynamic study carried out in the following 45 days and the patients were shifted to 4/day IC. There was a significant difference between the anticholinergic pre-treatment (293 ± 39 ml) and post-treatment (531 ± 81 ml) capacities (P < 0.001). The mean increase in bladder capacity in all patients was 237.6 ± 79.5 ml (83.5 ± 32.1%).
CONCLUSION: Patients with subacute SCI who were prescribed 6/day IC and were given an oral anticholinergic drug can be shifted to 4/day IC after 45 days without performing an early control urodynamic study if the patients use the drug properly. However in the long-run, periodic follow-up urodynamic studies should be carried out at appropriate intervals, according to the patients' clinical findings.

Entities:  

Keywords:  Anticholinergic therapy; Intermittent catheter frequency; Spinal cord injury; Urodynamics

Mesh:

Year:  2016        PMID: 26506983      PMCID: PMC5073755          DOI: 10.1179/2045772315Y.0000000065

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  11 in total

Review 1.  Neurogenic detrusor overactivity in adults: a review on efficacy, tolerability and safety of oral antimuscarinics.

Authors:  H Madersbacher; G Mürtz; M Stöhrer
Journal:  Spinal Cord       Date:  2013-06       Impact factor: 2.772

Review 2.  Oxybutynin in detrusor overactivity.

Authors:  Ananias Diokno; Michael Ingber
Journal:  Urol Clin North Am       Date:  2006-11       Impact factor: 2.241

3.  Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury.

Authors:  Michael Nosseir; Andreas Hinkel; Jürgen Pannek
Journal:  Neurourol Urodyn       Date:  2007       Impact factor: 2.696

4.  Are oxybutynin and trospium efficacious in the treatment of detrusor overactivity in spinal cord injury patients?

Authors:  N Hadiji; J G Previnaire; R Benbouzid; G Robain; C Leblond; R Mieusset; M Enjalbert; J M Soler
Journal:  Spinal Cord       Date:  2014-07-22       Impact factor: 2.772

5.  Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.

Authors:  Manfred Stöhrer; Gerd Mürtz; Guus Kramer; Frieder Schnabel; Edwin P Arnold; Jean-Jaques Wyndaele
Journal:  Eur Urol       Date:  2006-05-02       Impact factor: 20.096

6.  Bladder emptying over a period of 10-45 years after a traumatic spinal cord injury.

Authors:  R B Hansen; F Biering-Sørensen; J K Kristensen
Journal:  Spinal Cord       Date:  2004-11       Impact factor: 2.772

Review 7.  Pathogenesis of bacteriuria and infection in the spinal cord injured patient.

Authors:  Mike B Siroky
Journal:  Am J Med       Date:  2002-07-08       Impact factor: 4.965

8.  Bladder management in persons with spinal cord lesion.

Authors:  A Dahlberg; I Perttilä; E Wuokko; M Ala-Opas
Journal:  Spinal Cord       Date:  2004-12       Impact factor: 2.772

9.  Neurogenic bladder in patients with traumatic spinal cord injury: treatment and follow-up.

Authors:  N Yıldız; Y Akkoç; B Erhan; B Gündüz; B Yılmaz; R Alaca; H Gök; K Köklü; M Ersöz; E Cınar; H Karapolat; N Catalbaş; A N Bardak; I Turna; Y Demir; S Güneş; E Alemdaroğlu; H Tunç
Journal:  Spinal Cord       Date:  2014-04-15       Impact factor: 2.772

10.  Trospium chloride versus oxybutynin: a randomized, double-blind, multicentre trial in the treatment of detrusor hyper-reflexia.

Authors:  H Madersbacher; M Stöhrer; R Richter; H Burgdörfer; H J Hachen; G Mürtz
Journal:  Br J Urol       Date:  1995-04
View more
  1 in total

1.  Efficacy and safety of heat-sensitive moxibustion in the treatment of neurogenic bladder after spinal cord injury: A protocol for systematic review and meta-analysis.

Authors:  Qianqian Lin; Yafeng Ren; Kewei Chen; Huijie Duan; Meng Chen; Chengmei Liu
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.